Palisade Bio Inc (PALI)

Palisade Bio Inc (PALI) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $251M; returns 1 day -1.5%, 1 week -5.7%, 1 year -24.9%.

Palisade Bio, Inc. (PALI) is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for autoimmune, inflammatory, and fibrotic diseases, particularly gastrointestinal disorders.

Groups PALI belongs to

• Biotechnology
• Clinical Stage Biotech
• Pharmaceuticals
• Clinical Stage Biopharma
• Gastroenterology
• Healthcare
• Autoimmune Diseases
• Fibrosis
• Chronic Inflammatory Diseases
• Digestive Health
• Biopharmaceutical
• Drug Discovery
• Clinical Stage

PALI financial model: income statement, cash flow and balance sheet